new oral cancer drug in Canada called Sutent

July 2006

You'll see a new oral cancer drug in Canada called Sutent.

Sutent (sunitinib) is for treating gastrointestinal stromal tumours (GIST) that have become resistant to Gleevec (imatinib).

It works similarly to Gleevec. Both drugs block proteins needed for the tumour's growth.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

New guidelines clarify how to reduce the risk of ischemic stroke
Osteoporosis increased risk of death due to stroke with Evista (raloxifene)
Contraceptives Linessa is a new triphasic oral contraceptive in Canada
Vaccines Researchers are using large doses of chickenpox vaccine to prevent shingles
Vaccines new Gardasil vaccine to prevent cervical cancer and genital warts
Gastroenterology probiotics for "digestive health"
Heart Disease new brand of sildenafil called Revatio
Women's Health ACE inhibitors during the first trimester MIGHT increase the risk of birth defects
Women's Health codeine can be toxic to breastfed infants
Dermatology new ORAL "sunscreens" such as SunPill and Heliocare
Azilect and Zelapar are new options on the horizon for Parkinson's
questioning the benefits of taking daily multivitamin and mineral supplements
alarming patients about the safety of Humira (adalimumab) and Remicade (infliximab)
Hematology & Oncology new oral cancer drug in Canada called Sutent
Acetaminophen Consumers still aren't getting the message about the danger of taking too much acetaminophen
many drugs can cause sweating
Practice two new investigational drugs for type 2 diabetes, Januvia and Galvus